Deep Medicine Acquisition Corp (DMAQ) Financials

$2.98

$-5.41 (-64.48%)

As on 31-Jan-2024 19:59EDT

Market cap

$13 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

22

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15	Mar-14
Operating Revenue	0.09	--	--	--	--	--
Cost of Revenue	0.05	0.06	0.06	--	--	--
Gross Profit	0.05	-0.06	-0.06	--	--	--
Operating Expenses	1.88	2.11	0.41	--	--	--
Operating Profit (EBIT)	-1.75	-0.34	-0.46	--	--	--
Other Income	--	--	--	--	--	--
Profit before Tax	-1.56	-0.34	-0.41	--	--	--
Provision for Tax	0.10	0.06	-0.06	--	--	--
Profit after Tax (Net Income)	-1.55	-0.40	-0.36	--	--	--
Minority Interest	--	--	--	--	--	--
Consolidated Profit	-0.66	-0.40	-0.41	-0.08	--	--

Liabilities ($ Mln)	TTM	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15	Mar-14
Shareholder's Funds	-1.25	2.55	123.99	-0.01	--	--
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	4.43	4.43	4.43	0.51	--	--
Current Liabilities	3.71	2.80	0.54	0.04	--	--
Total Liabilities	10.59	9.78	128.95	0.54	--	--

Assets ($ Mln)	TTM	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15	Mar-14
Non-Current Assets	--	--	--	--	--	--
Current Assets	6.88	9.78	128.95	0.54	--	--
Total Assets	13.76	9.78	128.95	0.54	--	--
Total Debt*	--	1.87	0.50	0.50	--	--
Net Current Assets	--	6.98	128.42	0.50	--	--

Cashflow ($ Mln)	TTM	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15	Mar-14
Cash From Operating Activities	--	-1.04	-0.70	-0.07	--	--
Cash Flow from Investing Activities	--	120.42	-127.77	-127.77	--	--
Cash from Financing Activities	--	-119.67	128.84	0.73	--	--
Net Cash Inflow / Outflow	--	--	--	--	--	--

Financials Ratios	TTM	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15	Mar-14
Adjusted EPS ($)	--	--	--	--	--	--
Cash EPS ($)	--	--	--	--	--	--
Adjusted Book Value ($)	--	--	--	--	--	--
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	--	--	--	--	--
Free Cash Flow per Share ($)	--	--	--	--	--	--

Profitability Ratios	TTM	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15	Mar-14
ROCE (%)	--	-0.62	-0.57	--	--	--
ROE (%)	--	-0.63	-0.58	--	--	--
ROA (%)	-11.85	-0.58	-0.55	--	--	--
EBIT Margin (%)	-3,129.50	--	--	--	--	--
Net Margin (%)	-1,721.63	--	--	--	--	--
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	TTM	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15	Mar-14
Revenue Growth (%)	--	--	--	--	--	--
EBIT Growth (%)	-49.31	25.77	-482.94	--	--	--
Net Profit Growth (%)	92.47	-11.74	--	--	--	--
EPS Growth (%)	--	--	--	--	--	--
Book Value Growth (%)	--	--	--	--	--	--

Valuation Ratios	TTM	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15	Mar-14
Price / Earnings	--	--	--	--	--	--
Price / Book Value	22.01	--	--	--	--	--
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-8.23	1.98	315.78	--	--	--
Close Price ($)	11.65	10.62	9.92	--	--	--
High Price ($)	19.91	11.00	10.90	--	--	--
Low Price ($)	--	9.92	9.70	--	--	--
Market Cap ($ Cr)	12.90	--	--	--	--	--

Solvency Ratios	TTM	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15	Mar-14
Debt to Equity	--	0.73	0.00	-53.22	--	--
Short term debt to equity ratio	--	0.73	0.00	--	--	--
Current Ratio	1.86	3.50	240.27	13.12	--	--
Quick Ratio	1.86	--	--	--	--	--
Interest Coverage	-7.15	--	-55.85	--	--	--

Operating Efficiency Ratios	TTM	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15	Mar-14
Debtors to sales (%)	--	--	--	--	--	--
Asset Turnover	0.01	--	--	--	--	--
Receivable days	--	--	--	--	--	--
Inventory Days	--	--	--	--	--	--
Payable days	--	--	--	--	--	--
Cash Conversion Cycle	--	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.